Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04223245 · ClinicalTrials.gov registry record · NA

A Home Program Using Multimodal Sensory Feedback for People With Parkinson Disease

A NA study of Parkinson Disease, sponsored by Regis University.

Completed
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT04223245 is a NA study of Parkinson Disease that has completed, run by Regis University. The registered enrollment target is 26 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04223245, a NA study of Parkinson Disease, has completed, sponsored by Regis University.

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

People with Parkinson Disease (PWPD) have significant problems with velocity, safety and dual tasking during walking that may be secondary to poor automaticity. Sensory functions, especially visual dependence and proprioceptive integration are critical for efficient walking and are often impaired. This home program compares the use of multimodal sensory feedback during stepping and balance exercises in PWPD to a group without the sensory feedback performing the same basic exercises.

Conditions Studied

Interventions

  • BEHAVIORAL Exercise only
  • BEHAVIORAL exercise+multi-modal sensory feedback (MMSF)

Study Locations (1)

Colorado

  • Regis University - Denver

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2017-06-29
Est. Completion 2019-03-08
Phase NA

Sponsor

Regis University

8 total trials

What the Registry Record Tells You About NCT04223245

The ClinicalTrials.gov registry entry for NCT04223245 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (100% lower). The listed sponsor is Regis University, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Exercise only is the first listed.

NCT04223245 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT04223245 about?

NCT04223245 is a clinical study titled "A Home Program Using Multimodal Sensory Feedback for People With Parkinson Disease". People with Parkinson Disease (PWPD) have significant problems with velocity, safety and dual tasking during walking that may be secondary to poor automaticity. Sensory functions, especially visual dependence and proprioceptive integration are critical for efficient walking and are often impaired. T...

What is the current status of trial NCT04223245?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2017-06-29. Estimated completion is 2019-03-08.

What conditions does trial NCT04223245 study?

This clinical trial studies the following conditions: Parkinson Disease.

What interventions are being tested in trial NCT04223245?

The interventions under investigation include: Exercise only (BEHAVIORAL), exercise+multi-modal sensory feedback (MMSF) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04223245?

This trial is sponsored by Regis University, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04223245 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.